The global CAR T-cell therapy market is witnessing substantial growth over the forecast period of 2023 to 2028. This growth can be attributed to a number of factors, including growing prevalence of cancer, advances in cell therapy technology, and favorable regulatory policies. The market is also stimulated by a growing demand for advanced cancer tr